U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Gene expression data from the 786-O renal cell carcinoma cell line and its metastatic derivatives.

(Submitter supplied) Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14604
7 Samples
Download data: CEL
Series
Accession:
GSE32295
ID:
200032295
2.

Gene expression changes in 786-O cells in response to SUZ12 knockdown.

(Submitter supplied) Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6791
7 Samples
Download data: CEL
Series
Accession:
GSE35417
ID:
200035417
3.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

(Submitter supplied) Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL6791 GPL14604
26 Samples
Download data: CEL
Series
Accession:
GSE32299
ID:
200032299
4.

Gene expression changes in 786-O cells in response to 5DC treatment.

(Submitter supplied) Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6791
6 Samples
Download data: CEL
Series
Accession:
GSE32298
ID:
200032298
5.

Gene expression changes in response to VHL-reintroduction in metastatic 786-M1A cells.

(Submitter supplied) Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6791
6 Samples
Download data: CEL
Series
Accession:
GSE32297
ID:
200032297
6.

Deregulation of HIF-Responsive Demethylases Causes Synthetic Lethality Between the VHL Tumor Suppressor Gene and the EZH1 Histone Methyltransferase

(Submitter supplied) Comparison of ccRCC cells with high HIF or low HIF activity
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
3 Samples
Download data: TXT
7.

Cellular and molecular characterization of the altered metabolism in RCC

(Submitter supplied) RCC cells (786-O) were transfected with VHL. The parental cell line should be compared to the transfectant (+ VHL) under nomoxia as well as under hypoxia conditions. We want to distinct the VHL-mediated gene expression from the hypoxia-mediated and study the influence of both on the cellular metabolism.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS5810
Platform:
GPL6244
8 Samples
Download data: CEL
Series
Accession:
GSE65168
ID:
200065168
8.
Full record GDS5810

Hypoxia effect on von Hippel Lindau-overexpressing renal cell carcinoma cells

Analysis of renal cell carcinoma (RCC) 786-O cells transfected with von Hippel Lindau (VHL)-overexpression vector and cultured under hypoxia conditions (1% O2) for 24 hours. Results provide insight into overlap and differences of VHL- and hypoxia-dependent molecular alterations in RCC.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 protocol, 2 stress sets
Platform:
GPL6244
Series:
GSE65168
8 Samples
Download data: CEL
9.

Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss

(Submitter supplied) von Hippel-Lindau (VHL) is a critical tumor suppres- sor in clear cell renal cell carcinomas (ccRCCs). It is important to identify additional therapeutic targets in ccRCC downstream of VHL loss besides hypox- ia-inducible factor 2a (HIF2a). By performing a genome-wide screen, we identified Scm-like with four malignant brain tumor domains 1 (SFMBT1) as a candidate pVHL target. SFMBT1 was considered to be a transcriptional repressor but its role in cancer remains unclear. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
Platforms:
GPL23227 GPL20301
11 Samples
Download data: BW, XLSX
10.

Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology

(Submitter supplied) Clear cell renal cell carcinoma comprises two dominant subtypes, ccA and ccB, with gender disparity providing additional disease information. A third minor subgroup has distinct expression profiles consistent with von Hippel-Lindau wild type status and displays variant histology features.
Organism:
Homo sapiens
Type:
Expression profiling by array; Third-party reanalysis
Platform:
GPL4133
44 Samples
Download data: TXT
Series
Accession:
GSE33093
ID:
200033093
11.

A renal cancer-associated, renal tubule-specific, HIF-binding enhancer of oncogenic MYC and PVT1 expression

(Submitter supplied) Clear cell renal cell carcinoma is characterized by loss of function of the von Hippel-Lindau tumor suppressor gene (VHL) and unrestrained activation of hypoxia inducible transcription factors (HIF). Genetic and epigenetic determinants can impact on HIF pathways. A recent genome-wide association study identified single nucleotide polymorphisms (SNPs) in an intergenic region on chromosome 8 that modify the risk of developing renal cancer. more...
Organism:
Homo sapiens
Type:
Other
Platform:
GPL20301
3 Samples
Download data: BW
Series
Accession:
GSE84444
ID:
200084444
12.

Gene expression profiling of 786-O cells with ZHX2 and p65 knockdown

(Submitter supplied) We are examining the regulatory pathway of ZHX2 and p65 in clear cell renal cell carcinoma cell line 786-O
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL17692 GPL16686
10 Samples
Download data: CEL, CHP
Series
Accession:
GSE110094
ID:
200110094
13.

VHL Substrate Transcription Factor ZHX2 As An Oncogenic Driver In Clear Cell Renal Cell Carcinoma

(Submitter supplied) Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bound VHL only when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target and its hydroxylation allowed VHL to regulate its protein stability. more...
Organism:
Homo sapiens
Type:
Genome binding/occupancy profiling by high throughput sequencing
Platform:
GPL16791
6 Samples
Download data: BW
Series
Accession:
GSE109953
ID:
200109953
14.

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis and ATM-Mediated DNA Damage Response

(Submitter supplied) Gene expression data from VHL teratomas comparing genes differentially expressed based on apoptotic response to tumor microenvironment. Abstract BACKGROUND: The risk relevance of the P81S von Hippel-Lindau (VHL) gene hotspot mutation identified in clear cell renal cell carcinoma from individuals exposed occupationally to trichloroethylene (TCE) is not known. VHL mutations in hereditary VHL syndrome strongly correlate with phenotypic associations, but specific sporadic mutations in VHL that uniquely alter its protein function may provide a selective growth advantage for somatic cells harboring these mutations. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS4865
Platform:
GPL11533
10 Samples
Download data: CEL
Series
Accession:
GSE37464
ID:
200037464
15.
Full record GDS4865

P81S von Hippel-Lindau mutation effect on embryonic stem cell teratomas

Analysis of teratomas from nude mice injected with von Hippel-Lindau (VHL)-deficient mouse ES cells stably expressing human P81S VHL protein. P81S teratomas are resistant to ionizing radiation-induced apoptosis. Results provide insight into molecular mechanisms underlying this adaptive response.
Organism:
Mus musculus
Type:
Expression profiling by array, transformed count, 3 genotype/variation, 2 other sets
Platform:
GPL11533
Series:
GSE37464
10 Samples
Download data: CEL
16.

Microarray analysis of gene expression after suppression of PBRM1 or KDM5C in 786-O VHL+/+ or VHL-/- cells

(Submitter supplied) 1. PBRM1 loss elicited very similar transcriptional changes as KDM5C loss; 2. PBRM1 loss, and to a lesser extent KDM5C loss, elicited greater transcriptional response in VHL-/- cells than that in VHL+/+ cells.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10904
18 Samples
Download data: IDAT
Series
Accession:
GSE108229
ID:
200108229
17.

USP13 Promotes Deubiquitination of ZHX2 and Tumorigenesis in Kidney Cancer

(Submitter supplied) Clear cell renal cell carcinoma (ccRCC) is characterized by loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor alpha (including HIF1alpha and HIF2alpha) and Zinc Fingers And Homeoboxes 2 (ZHX2). Our recent research showed that ZHX2 contributed to ccRCC tumorigenesis in a HIF independent manner. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
18 Samples
Download data: SF, XLSX
18.

miRNA expression in primary renal carcinomas, subgrouped based on HIF1α expression

(Submitter supplied) Clear cell renal cell carcinoma (ccRCC), the most common type of renal cancer is often associated with inactivation of the tumor suppressor gene von-Hippel Lindau (VHL), leading to stable expression of hypoxia inducible factors, HIF1α and HIF2α. Although HIF1α functions as a tumor suppressor gene, majority of ccRCCs constitutively express HIF1α, stratifying VHL-deficient ccRCCs into groups which express either both HIF1α and HIF2α (H1H2) or HIF2α exclusively (H2). more...
Organism:
Homo sapiens; synthetic construct
Type:
Non-coding RNA profiling by array
Platform:
GPL8786
26 Samples
Download data: CEL
Series
Accession:
GSE47582
ID:
200047582
19.

Effect of depletion of vhl-1 on gene expression in young adult C. elegans

(Submitter supplied) To investigate the function of vhl-1 on gene expression in C. elegans we compared vhl-1 loss of function mutants (CB5602) to wild type animals.
Organism:
Caenorhabditis elegans
Type:
Expression profiling by high throughput sequencing
Platform:
GPL22765
6 Samples
Download data: TXT
Series
Accession:
GSE224016
ID:
200224016
20.

Next Generation Sequencing of 786-O-Ctrl and786-O-VHL Transcriptomes

(Submitter supplied) Inactivation of the E3 ubiquitin ligase protein von Hippel-Lindau (VHL) is critical to clear cell renal cell carcinomas (ccRCC) and VHL syndrome. VHL loss leads to stabilization of hypoxia-inducible factor α (HIFα) and other substrate proteins, which may drive various tumor-promoting pathways. This process is likely reversible, because even in the highly aggressive human VHL-deficient ccRCC cell line 786-O, restoring VHL expression almost completely abolishes orthotopic tumor formation in immuno-deficient mice. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
4 Samples
Download data: TXT
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=5|blobid=MCID_67503fc951e3a106b4563f20|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center